肿瘤治疗药物及其辅助用药不合理医嘱原因的点评分析  

Comment Analysis on Reasons for Unreasonable Doctor’s Advice of Anti-tumor Drugs and Their Adjuvant Drugs

作　　者：缪旭[1] 乔晨 徐遥[1] MIAO Xu;QIAO Chen;XU Yao(The Hospital Affiliated to Jiangsu University, Zhenjiang Jiangsu 212001, China)

机构地区：[1]江苏大学附属医院

出　　处：《抗感染药学》2019年第4期600-602,共3页Anti-infection Pharmacy

摘　　要：目的:分析肿瘤住院患者不合理医嘱用药的原因,为肿瘤患者合理用药提供参考。方法:抽取2017年4月-2018年3月间收治的肿瘤住院患者用药医嘱240例,点评用药医嘱中不合理用药医嘱发生的原因。结果:240例用药医嘱中,不合理用药医嘱33例占13.75%。结论:通过抗肿瘤药物专项用药医嘱点评,提高了肿瘤科临床合理用药水平,确保了患者用药的安全性合理性。Objective: To analyze the medication reasons of irrational doctor’s advice in in-patients with tumor, and to provide a reference for rational medication for patients with tumor. Methods: 240 cases of in-patients with tumor treated from April 2017 to March 2018 were selected, and the causes of unreasonable doctor’s advice were reviewed. Results: Among 240 patients with medication orders, 33 patients with unreasonable doctor’s advice accounted for 13.75%.Conclusion: The comments on special medical orders for anti-tumor drugs can improve the level of rational drug use in the clinical oncology department, and ensure the safety and rationality of drug use for patients.

关 键 词：处方点评 肿瘤治疗药物 辅助用药 合理用药 

分 类 号：R969.3[医药卫生—药理学]